Combination of an Anti-PD1 Antibody With Tisagenlecleucel Reinfusion in Children, Adolescents and Young Adults With Acute Lymphoblastic Leukemia After Loss of Persistence

Clinical trial NCT05310591 · RECRUITING

Trial details

NCT number: NCT05310591
Sponsor: Assistance Publique - Hôpitaux de Paris
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

B Acute Lymphoblastic Leukemia Acute Lymphoblastic Leukemia, in Relapse

Start date: 2023-03-15
Primary completion: 2027-03-01
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.